Shares of three biopharma companies are falling after the FDA revealed a potentially fatal diabetes drug risk, with CNBC's Mike Huckman.
Debating whether it's time to buy big pharma, with Bernie McGinn, McGinn, McKean & O'Neill CIO and CNBC's Erin Burnett.
A new study in a major medical journal is reigniting the debate over whether patients should use cheap drugs or an expensive device to impro...
The NYSE announces a crackdown on insider trading, with Richard Ketchum, NYSE Regulation, Inc. CEO
Discussing big pharma's prospects, with John Leichlieter, Eli Lilly CEO and the Fast Money team.
Nobel Biocare posted a 42% drop second-quarter profit Monday, missing targets. CEO Domenico Scala spoke to CNBC about the outlook for the se...
Posts |
COMPANY : ARIAD Pharmaceuticals
15 May 2008
This is gonna be a crazy couple of days... Read More
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes